$2.94 Billion is the total value of ARMISTICE CAPITAL, LLC's 106 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WMT | New | WALMART INC | $53,368,000 | – | 370,225 | +100.0% | 1.82% | – |
| ORLY | New | OREILLY AUTOMOTIVE INC | $40,995,000 | – | 90,583 | +100.0% | 1.39% | – |
| ULTA | New | ULTA BEAUTY INC | $39,715,000 | – | 138,304 | +100.0% | 1.35% | – |
| TGT | New | TARGET ORD | $31,544,000 | – | 178,687 | +100.0% | 1.07% | – |
| BGS | New | B & G FOODS INC NEW | $29,505,000 | – | 1,064,000 | +100.0% | 1.00% | – |
| BURL | New | BURLINGTON STORES INC | $25,486,000 | – | 97,443 | +100.0% | 0.87% | – |
| BABA | New | ALIBABA GROUP HLDG LTDsponsored ads | $24,204,000 | – | 104,000 | +100.0% | 0.82% | – |
| DXCM | New | DEXCOM INC | $23,662,000 | – | 64,000 | +100.0% | 0.80% | – |
| ILMN | New | ILLUMINA INC | $18,500,000 | – | 50,000 | +100.0% | 0.63% | – |
| BSX | New | BOSTON SCIENTIFIC CORP | $17,975,000 | – | 500,000 | +100.0% | 0.61% | – |
| POST | New | POST HLDGS INC | $17,778,000 | – | 176,000 | +100.0% | 0.60% | – |
| VTRS | New | VIATRIS INC | $17,541,000 | – | 936,000 | +100.0% | 0.60% | – |
| CLX | New | CLOROX CO DEL | $12,115,000 | – | 60,000 | +100.0% | 0.41% | – |
| PG | New | PROCTER AND GAMBLE CO | $12,105,000 | – | 87,000 | +100.0% | 0.41% | – |
| NTRA | New | NATERA INC | $11,544,000 | – | 116,000 | +100.0% | 0.39% | – |
| AYTU | New | AYTU BIOSCIENCE INC | $7,973,000 | – | 1,333,334 | +100.0% | 0.27% | – |
| WDAY | New | WORKDAY INCcl a | $7,188,000 | – | 30,000 | +100.0% | 0.24% | – |
| PRTS | New | CARPARTS COM INC | $6,815,000 | – | 550,000 | +100.0% | 0.23% | – |
| NEPT | New | NEPTUNE WELLNESS SOLUTIONS I | $6,500,000 | – | 4,166,666 | +100.0% | 0.22% | – |
| ADBE | New | ADOBE SYSTEMS INCORPORATED | $6,001,000 | – | 12,000 | +100.0% | 0.20% | – |
| DT | New | DYNATRACE INC | $5,885,000 | – | 136,000 | +100.0% | 0.20% | – |
| CRWD | New | CROWDSTRIKE HLDGS INCcl a | $5,296,000 | – | 25,000 | +100.0% | 0.18% | – |
| SELB | New | SELECTA BIOSCIENCES INC | $4,957,000 | – | 1,636,000 | +100.0% | 0.17% | – |
| CRI | New | CARTERS INC | $4,930,000 | – | 52,404 | +100.0% | 0.17% | – |
| VFC | New | V F CORP | $4,252,000 | – | 49,781 | +100.0% | 0.14% | – |
| RZLT | New | REZOLUTE INC | $4,005,000 | – | 333,990 | +100.0% | 0.14% | – |
| BXRX | New | BAUDAX BIO INC | $3,538,000 | – | 3,503,351 | +100.0% | 0.12% | – |
| LMNL | New | LIMINAL BIOSCIENCES INC | $2,374,000 | – | 565,242 | +100.0% | 0.08% | – |
| RWLK | New | REWALK ROBOTICS LTD | $1,841,000 | – | 1,394,944 | +100.0% | 0.06% | – |
| PTE | New | POLARITYTE INC | $1,149,000 | – | 1,689,220 | +100.0% | 0.04% | – |
| CBLI | New | CLEVELAND BIOLABS INC | $1,104,000 | – | 320,053 | +100.0% | 0.04% | – |
| SRGA | New | SURGALIGN HOLDINGS INC | $955,000 | – | 436,000 | +100.0% | 0.03% | – |
| TMDI | New | TITAN MED INC | $477,000 | – | 278,787 | +100.0% | 0.02% | – |
| CYTH | New | CYCLO THERAPEUTICS INC | $435,000 | – | 100,000 | +100.0% | 0.02% | – |
| CYTHW | New | CYCLO THERAPEUTICS INC*w exp 11/14/202 | $156,000 | – | 50,000 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.